Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Au

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Urology|November 4, 2024
Editorial CommentDaniel Au
Urology|June 23, 2023
Evaluating Financial Toxicity in Urologic PracticeVassili Glazyrine, Daniel Au, Jared Starkey, et al.
Urology|May 4, 2019
National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate CancerAllison May, Jonathon Henke, Daniel Au, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 13, 2021
Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patientsDaniel Au, Eugene K Lee, Taiye O Popoola, et al.
Molecular Genetics and Genomics : MGG|March 11, 2021
Performance comparison: exome sequencing as a single test replacing Sanger sequencingHila Fridman, Concetta Bormans, Moshe Einhorn, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Urology|November 4, 2024
Editorial CommentDaniel Au
Urology|June 23, 2023
Evaluating Financial Toxicity in Urologic PracticeVassili Glazyrine, Daniel Au, Jared Starkey, et al.
Urology|May 4, 2019
National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate CancerAllison May, Jonathon Henke, Daniel Au, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 13, 2021
Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patientsDaniel Au, Eugene K Lee, Taiye O Popoola, et al.
Molecular Genetics and Genomics : MGG|March 11, 2021
Performance comparison: exome sequencing as a single test replacing Sanger sequencingHila Fridman, Concetta Bormans, Moshe Einhorn, et al.
Pageof 1